Literature DB >> 23253068

A new protocol to determine the solubility of drugs into polymer matrixes.

Aurélien Mahieu1, Jean-François Willart, Emeline Dudognon, Florence Danède, Marc Descamps.   

Abstract

In this paper we present a new protocol to determine faster the solubility of drugs into polymer matrixes. The originality of the method lies in the fact that the equilibrium saturated states are reached by demixing of supersaturated amorphous solid solutions and not by dissolution of crystalline drug into the amorphous polymer matrix as for usual methods. The equilibrium saturated states are thus much faster to reach due to the extra molecular mobility resulting from the strong plasticizing effect associated with the supersaturation conditions. The method is validated using the indomethacin/polyvinylpyrrolidone mixture whose solubility diagram was previously determined by usual techniques. The supersaturated states have been directly obtained in the solid state by comilling, and the investigations have been performed by differential scanning calorimetry and powder X-ray diffraction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23253068     DOI: 10.1021/mp3002254

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  16 in total

1.  Probing the effects of experimental conditions on the character of drug-polymer phase diagrams constructed using Flory-Huggins theory.

Authors:  Conor Donnelly; Yiwei Tian; Catherine Potter; David S Jones; Gavin P Andrews
Journal:  Pharm Res       Date:  2014-07-30       Impact factor: 4.200

2.  Molecular indicators of surface and bulk instability of hot melt extruded amorphous solid dispersions.

Authors:  Ziyi Yang; Kathrin Nollenberger; Jessica Albers; Duncan Craig; Sheng Qi
Journal:  Pharm Res       Date:  2014-10-01       Impact factor: 4.200

Review 3.  Physical Stability of Amorphous Solid Dispersions: a Physicochemical Perspective with Thermodynamic, Kinetic and Environmental Aspects.

Authors:  Xia Lin; Yang Hu; Lei Liu; Lili Su; Na Li; Jing Yu; Bo Tang; Ziyi Yang
Journal:  Pharm Res       Date:  2018-04-23       Impact factor: 4.200

4.  Screening methodologies for the development of spray-dried amorphous solid dispersions.

Authors:  Íris Duarte; José Luís Santos; João F Pinto; Márcio Temtem
Journal:  Pharm Res       Date:  2014-08-19       Impact factor: 4.200

5.  The Investigation of Flory-Huggins Interaction Parameters for Amorphous Solid Dispersion Across the Entire Temperature and Composition Range.

Authors:  Yiwei Tian; Kaijie Qian; Esther Jacobs; Esther Amstad; David S Jones; Lorenzo Stella; Gavin P Andrews
Journal:  Pharmaceutics       Date:  2019-08-19       Impact factor: 6.321

6.  Theoretical prediction of a phase diagram for solid dispersions.

Authors:  Bin Tian; Xiaoyan Wang; Yuanyuan Zhang; Keru Zhang; Yu Zhang; Xing Tang
Journal:  Pharm Res       Date:  2014-08-28       Impact factor: 4.200

7.  Solid-state characterization of Felodipine-Soluplus amorphous solid dispersions.

Authors:  Jiannan Lu; Kristina Cuellar; Nathan I Hammer; Seongbong Jo; Andreas Gryczke; Karl Kolter; Nigel Langley; Michael A Repka
Journal:  Drug Dev Ind Pharm       Date:  2015-11-04       Impact factor: 3.225

8.  Drug-Polymer Solubility Determination: A New Thermodynamic Model Free from Lattice Theory Assumptions.

Authors:  Luis Almeida E Sousa; Kata J Dömötör; Mafalda Paiva; Constança Cacela
Journal:  Pharm Res       Date:  2019-11-01       Impact factor: 4.200

9.  Enhancement of the physical stability of amorphous indomethacin by mixing it with octaacetylmaltose. inter and intra molecular studies.

Authors:  E Kaminska; K Adrjanowicz; D Zakowiecki; B Milanowski; M Tarnacka; L Hawelek; M Dulski; J Pilch; W Smolka; I Kaczmarczyk-Sedlak; K Kaminski
Journal:  Pharm Res       Date:  2014-05-15       Impact factor: 4.200

10.  Investigation of the in vitro performance difference of drug-Soluplus® and drug-PEG 6000 dispersions when prepared using spray drying or lyophilization.

Authors:  Mohammad A Altamimi; Steven H Neau
Journal:  Saudi Pharm J       Date:  2016-09-30       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.